Format

Send to

Choose Destination
Yale J Biol Med. 2015 Sep 3;88(3):265-9. eCollection 2015 Sep.

Marijuana for Glaucoma: A Recipe for Disaster or Treatment?

Author information

1
Penn State Hershey Cancer Institute, Penn State College of Medicine, Hershey, Pennsylvania.
2
Department of Ophthalmology and Visual Science, Yale School of Medicine, New Haven, Connecticut.
3
Icahn School of Medicine at Mount Sinai/New York Eye and Ear Infirmary of Mount Sinai, New York, New York.

Abstract

Marijuana has been shown to lower intraocular pressure (IOP) but with limited duration of action and numerous adverse effects. Use of marijuana to lower IOP as a means of glaucoma treatment would require frequent use throughout the day, leading to significant adverse effects, possible progression toward Cannabis Use Disorder (CUD), and/or withdrawal symptoms. The treatment of glaucoma based on the cannabis plant or drugs based on the cannabinoid molecule should be considered carefully before being prescribed. Considerations should include the adverse physical and psychological adverse effects, including substance abuse. Currently, the deleterious effects of marijuana outweigh the benefits of its IOP-lowering capacity in most glaucoma patients. Under extremely rare circumstances, a few categories of glaucoma patients may be potential candidates for treatment with medical marijuana. Further studies on alternate routes and more focused means of cannabinoid molecule delivery to the eye for glaucoma treatment are needed.

KEYWORDS:

addiction; cannabis use disorder; glaucoma; intraocular pressure; medical marijuana

PMID:
26339209
PMCID:
PMC4553646
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center